EE168 Budget Impact Analysis of Adopting Lanreotide in the Treatment of Acromegaly and GEP-NET at Public Hospitals in Saudi Arabia

Journal article

Peer reviewed

F. Alnajjar, H. Raef, B. Alharbi, M. Mahrous, M. Almalki, A. Al rumaih, N. Kamas, M. Alharbi, H. Magdy, A. Emam, …

Value in health, Vol.26(6), pp.S90-S90

06/2023

Metrics

5 Record Views

Title: EE168 Budget Impact Analysis of Adopting Lanreotide in the Treatment of Acromegaly and GEP-NET at Public Hospitals in Saudi Arabia
Creators - without role: F. Alnajjar - Riyadh Elm University
H. Raef - King Faisal Specialist Hospital & Research Centre
B. Alharbi - Ministry of Defense
M. Mahrous - Ministry of Defense and Aviation (MODA) Hospital, Riyadh, Saudi Arabia
M. Almalki - King Fahd Medical City
A. Al rumaih - Ministry of Defense and Aviation (MODA) Hospital, Riyadh, Saudi Arabia
N. Kamas - King Fahad Specialist Hospital
M. Alharbi - CAE Solutions
H. Magdy - Ipsen, Dubai, United Arab Emirates
A. Emam - Ipsen, Riyadh, Saudi Arabia
Matar Mohammed Alharbi - Alfaisal University
Publication Details: Value in health, Vol.26(6), pp.S90-S90
Publisher: Elsevier Inc
Identifiers: 9913492108331
Academic Unit: Alfaisal University
Language: English
Resource Type: Journal article